+++
title = "Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in January"
description = "Drugmakers including Pfizer Inc , GlaxoSmithKline PLC , Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors."
date = "2022-12-31 07:17:42"
slug = "63afe1f71f13f599192ccd7b"
image = "https://i.imgur.com/umsquL4.jpg"
score = "1104"
categories = ['drug', 'increase', 'raise']
+++

Drugmakers including Pfizer Inc , GlaxoSmithKline PLC , Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

## Highlights

- Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb and AstraZeneca plan to raise prices in the United States on more than 350 unique drugs in early January.
- The increases are on list prices, which do not include rebates to pharmacy benefit managers and other discounts.
- Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira arm.
- GSK is followed by GSK, with planned increases so far on 26 unique drugs, including nearly a 7% increase on its popular shingles vaccine Shingrix.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-raise-prices-least-350-drugs-us-january-2022-12-30/">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
